Skip to main content
Top
Published in: Child's Nervous System 12/2012

01-12-2012 | Original Paper

Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome

Authors: Kuntal Kanti Das, Anant Mehrotra, Anup P. Nair, Shaleen Kumar, Arun K. Srivastava, Rabi N. Sahu, Raj Kumar

Published in: Child's Nervous System | Issue 12/2012

Login to get access

Abstract

Background and purpose

Glioblastoma in the pediatric age group is relatively rare. As a result, it has been difficult to deduce any consistent clinico-radiological and pathological profiles on these patients. Also, the prognostic factors affecting the survival in pediatric glioblastoma are not as well defined as in adults.

Patients and methods

In this retrospective series, 65 pediatric patients (age ≤ 18 years) from January 1995 to December 2011 with histopathologically proven diagnosis of intracranial glioblastoma were studied. Clinico-radiological, pathological, treatment, and follow-up data were collected. Progression-free and overall survivals were assessed using the Kaplan–Meier method.

Results

The male-to-female ratio was 2.6:1 with a mean age of 13.29 ± 4.53 years (range 2–18 years). Headache with or without vomiting (n = 51, 78 %), followed by seizures (n = 42, 65 %), and focal deficits (n = 31, 47 %) were the leading symptoms. Forty-nine (75 %) patients had tumors located superficially, whereas there were 16 patients with deeply located glioblastomas (25 %). Gross total tumor excision was achieved in 43 (66 %) patients, while the remaining patients had incomplete excision (n = 22, 34 %). Mean follow-up was 17.7 months (range 1.5–119 months). The median progression-free and overall survivals were 10 and 20 months, respectively. Extent of resection was found to be the independent predictor of survival (p value = 0.002).

Conclusion

Pediatric glioblastomas are associated with longer progression-free as well as overall survivals. Extent of tumor resection is the strongest predictor of survival in pediatric glioblastoma. Hence, an aggressive surgical resection may fetch a better outcome in children with glioblastoma.
Literature
1.
go back to reference Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061–1083PubMedCrossRef Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD (2009) Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 18:1061–1083PubMedCrossRef
2.
go back to reference Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, Kim IH, Ahn HS, Park SH, Kim SK (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6(2):145–9PubMedCrossRef Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG, Kim IH, Ahn HS, Park SH, Kim SK (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6(2):145–9PubMedCrossRef
3.
go back to reference Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS, Mansur DB (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80(4):1117–21PubMedCrossRef Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM, Simpson JR, Limbrick DL, Park TS, Mansur DB (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80(4):1117–21PubMedCrossRef
4.
go back to reference McLendon RE, Halperin EC (2003) Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98(8):1745–8PubMedCrossRef McLendon RE, Halperin EC (2003) Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98(8):1745–8PubMedCrossRef
5.
go back to reference Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR (1996) Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neurooncol 27(3):259–66PubMedCrossRef Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR (1996) Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neurooncol 27(3):259–66PubMedCrossRef
6.
go back to reference Chandler KL, Prados MD, Malec M, Wilson CB (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32(5):716–20, discussion 720PubMedCrossRef Chandler KL, Prados MD, Malec M, Wilson CB (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32(5):716–20, discussion 720PubMedCrossRef
7.
go back to reference Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11(3):274–80PubMedCrossRef Suri V, Das P, Pathak P, Jain A, Sharma MC, Borkar SA, Suri A, Gupta D, Sarkar C (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11(3):274–80PubMedCrossRef
8.
go back to reference Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada K, Kuratsu J, Ishimaru Y, Ushio Y (2004) The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg 101:219–26PubMedCrossRef Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada K, Kuratsu J, Ishimaru Y, Ushio Y (2004) The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg 101:219–26PubMedCrossRef
9.
go back to reference Naydenova E, Tzekova C, Minkina K, Nachevb S, Romanskya K, Bussarskya V (2011) Long-term survival with primary glioblastoma multiforme: a clinical study in Bulgarian patients. Case Rep Oncol 4:1–11CrossRef Naydenova E, Tzekova C, Minkina K, Nachevb S, Romanskya K, Bussarskya V (2011) Long-term survival with primary glioblastoma multiforme: a clinical study in Bulgarian patients. Case Rep Oncol 4:1–11CrossRef
10.
go back to reference Artico M, Cervoni L, Celli P, Salvati M, Palma L (1993) Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst 9:7–9PubMedCrossRef Artico M, Cervoni L, Celli P, Salvati M, Palma L (1993) Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst 9:7–9PubMedCrossRef
11.
go back to reference Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64(19):6892–9PubMedCrossRef Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64(19):6892–9PubMedCrossRef
12.
go back to reference Mineo JF, Quintin-Roue I, Lucas B, Buburusan V, Besson G (2002) Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 48(6):500–9, Article in FrenchPubMed Mineo JF, Quintin-Roue I, Lucas B, Buburusan V, Besson G (2002) Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 48(6):500–9, Article in FrenchPubMed
13.
go back to reference Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46(2):183–8PubMedCrossRef Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46(2):183–8PubMedCrossRef
14.
go back to reference Salcman M (1985) Supratentorial gliomas: clinical features and surgical therapy. In: Wilkins RH, Rengachary SS (eds) Neurosurgery. McGraw Hills, New York, pp 579–90 Salcman M (1985) Supratentorial gliomas: clinical features and surgical therapy. In: Wilkins RH, Rengachary SS (eds) Neurosurgery. McGraw Hills, New York, pp 579–90
15.
go back to reference Ozbek N, Cakir S, Gursel B, Meydan D (2004) Prognostic significance of seizure in patients with glioblastoma multiforme. Neurol India 52(1):76–8PubMed Ozbek N, Cakir S, Gursel B, Meydan D (2004) Prognostic significance of seizure in patients with glioblastoma multiforme. Neurol India 52(1):76–8PubMed
16.
go back to reference Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112(5):997–1004PubMedCrossRef Chaichana K, Parker S, Olivi A, Quiñones-Hinojosa A (2010) A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 112(5):997–1004PubMedCrossRef
17.
go back to reference Lemm D, de Oliveira FH, Bernays RL, Kockro RA, Kollias S, Fischer I, Rushing EJ (2012) Rare suprasellar glioblastoma: report of two cases and review of the literature. Brain Tumor Pathol Lemm D, de Oliveira FH, Bernays RL, Kockro RA, Kollias S, Fischer I, Rushing EJ (2012) Rare suprasellar glioblastoma: report of two cases and review of the literature. Brain Tumor Pathol
18.
go back to reference Kalina P (2012) Pediatric cerebellar hemorrhagic glioblastoma multiforme. Open Neuroimag J 6:13–5PubMedCrossRef Kalina P (2012) Pediatric cerebellar hemorrhagic glioblastoma multiforme. Open Neuroimag J 6:13–5PubMedCrossRef
19.
go back to reference Mcknight TR, Lamborn KR, Love TD et al (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 106:660–66PubMedCrossRef Mcknight TR, Lamborn KR, Love TD et al (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within grades II and III gliomas. J Neurosurg 106:660–66PubMedCrossRef
20.
go back to reference Ekici MA, Bulut T, Tucer B, Kurtsoy A (2011) Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas. Turk Neurosurg 21(3):271–9PubMed Ekici MA, Bulut T, Tucer B, Kurtsoy A (2011) Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas. Turk Neurosurg 21(3):271–9PubMed
21.
go back to reference Karremann M, Rausche U, Fleischhack G, Nathrath M, Pietsch T, Kramm CM, Wolff JE (2010) Clinical and epidemiological characteristics of pediatric gliosarcomas. J Neurooncol 97(2):257–65PubMedCrossRef Karremann M, Rausche U, Fleischhack G, Nathrath M, Pietsch T, Kramm CM, Wolff JE (2010) Clinical and epidemiological characteristics of pediatric gliosarcomas. J Neurooncol 97(2):257–65PubMedCrossRef
22.
go back to reference Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM (2009) Pediatric giant cell glioblastoma: new insights into a rare tumor entity. Neuro Oncol 11(3):323–9, Epub 2008 Dec 2PubMedCrossRef Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM (2009) Pediatric giant cell glioblastoma: new insights into a rare tumor entity. Neuro Oncol 11(3):323–9, Epub 2008 Dec 2PubMedCrossRef
23.
go back to reference Klein R, Mölenkamp G, Sörensen N, Roggendorf W (1998) Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs Nerv Syst 14(6):288–91PubMedCrossRef Klein R, Mölenkamp G, Sörensen N, Roggendorf W (1998) Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period. Childs Nerv Syst 14(6):288–91PubMedCrossRef
24.
go back to reference Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children’s Cancer Study Group. J Neurooncol 7(2):165–77PubMedCrossRef Sposto R, Ertel IJ, Jenkin RD, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Children’s Cancer Study Group. J Neurooncol 7(2):165–77PubMedCrossRef
25.
go back to reference Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, be Langer K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–96PubMedCrossRef Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, be Langer K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–96PubMedCrossRef
26.
go back to reference Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, Finlay JL, Children’s Cancer Group (2003) The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol 5(3):197–207PubMedCrossRef Pollack IF, Boyett JM, Yates AJ, Burger PC, Gilles FH, Davis RL, Finlay JL, Children’s Cancer Group (2003) The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience. Neuro Oncol 5(3):197–207PubMedCrossRef
27.
go back to reference Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children’s Cancer Group. J Clin Oncol 13(1):112–23PubMed Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children’s Cancer Group. J Clin Oncol 13(1):112–23PubMed
28.
go back to reference Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D, Griffiths PD, Doz F, Ironside J, Robson K, Hobson R, Dugan M, Pearson AD, Vassal G, Frappaz D (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20(24):4684–91PubMedCrossRef Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D, Griffiths PD, Doz F, Ironside J, Robson K, Hobson R, Dugan M, Pearson AD, Vassal G, Frappaz D (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20(24):4684–91PubMedCrossRef
29.
go back to reference Broniscer A, Chintagumpala M, Fouladi M, Krasin MJ, Kocak M, Bowers DC, Iacono LC, Merchant TE, Stewart CF, Houghton PJ, Kun LE, Ledet D, Gajjar A (2006) Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 76(3):313–9PubMedCrossRef Broniscer A, Chintagumpala M, Fouladi M, Krasin MJ, Kocak M, Bowers DC, Iacono LC, Merchant TE, Stewart CF, Houghton PJ, Kun LE, Ledet D, Gajjar A (2006) Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 76(3):313–9PubMedCrossRef
30.
go back to reference Winger MJ, Macdonald DR, Cairncross JG (1989) Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71(4):487–93PubMedCrossRef Winger MJ, Macdonald DR, Cairncross JG (1989) Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71(4):487–93PubMedCrossRef
31.
go back to reference Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M (1990) Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 18(1):9–17PubMedCrossRef Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M (1990) Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother Oncol 18(1):9–17PubMedCrossRef
32.
go back to reference Campbell JW, Pollack IF, Martinez AJ, Shultz B (1996) High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38(2):258–64PubMedCrossRef Campbell JW, Pollack IF, Martinez AJ, Shultz B (1996) High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neurosurgery 38(2):258–64PubMedCrossRef
33.
go back to reference Mallick S, Goyal S, Puri T, Joshi N, Julka PK, Rath GK (2010) Pediatric glioblastoma treatment and clinical outcome: an institutional experience. J Clin Oncol 28, (suppl; abstr e12513) Mallick S, Goyal S, Puri T, Joshi N, Julka PK, Rath GK (2010) Pediatric glioblastoma treatment and clinical outcome: an institutional experience. J Clin Oncol 28, (suppl; abstr e12513)
34.
go back to reference Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C (2005) Glioblastoma multiforme with long-term survival. Neurol India 53:329–32PubMedCrossRef Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C (2005) Glioblastoma multiforme with long-term survival. Neurol India 53:329–32PubMedCrossRef
Metadata
Title
Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome
Authors
Kuntal Kanti Das
Anant Mehrotra
Anup P. Nair
Shaleen Kumar
Arun K. Srivastava
Rabi N. Sahu
Raj Kumar
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 12/2012
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-012-1890-x

Other articles of this Issue 12/2012

Child's Nervous System 12/2012 Go to the issue